{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:11:05Z","timestamp":1794960665172,"version":"4.9.1"},"reference-count":50,"publisher":"American Society of Hematology","issue":"13","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,9]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>There has been an increase in volume as well as an improvement in overall survival (OS) after hematopoietic cell transplantation (HCT) for hematologic disorders. It is unknown if these changes have affected racial\/ethnic minorities equally. In this observational study from the Center for International Blood and Marrow Transplant Research of 79 904 autologous (auto) and 65 662 allogeneic (allo) HCTs, we examined the volume and rates of change of autoHCT and alloHCT over time and trends in OS in 4 racial\/ethnic groups: non-Hispanic Whites (NHWs), non-Hispanic African Americans (NHAAs), and Hispanics across 5 2-year cohorts from 2009 to 2018. Rates of change were compared using Poisson model. Adjusted and unadjusted Cox proportional hazards models examined trends in mortality in the 4 racial\/ethnic groups over 5 study time periods. The rates of increase in volume were significantly higher for Hispanics and NHAAs vs NHW for both autoHCT and alloHCT. Adjusted overall mortality after autoHCT was comparable across all racial\/ethnic groups. NHAA adults (hazard ratio [HR] 1.13; 95% confidence interval [CI] 1.04-1.22; P\u00a0= .004) and pediatric patients (HR 1.62; 95%\u00a0CI 1.3-2.03; P\u00a0&amp;lt; .001) had a higher risk of mortality after alloHCT than NHWs. Improvement in OS over time was seen in all 4 groups after both autoHCT and alloHCT. Our study shows the rate of change for the use of autoHCT and alloHCT is higher in NHAAs and Hispanics than in NHWs. Survival after autoHCT and alloHCT improved over time; however, NHAAs have worse OS after alloHCT, which has persisted. Continued efforts are needed to mitigate disparities for patients requiring alloHCT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012469","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:58:00Z","timestamp":1714049880000},"page":"3497-3506","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Trends in volumes and survival after hematopoietic cell transplantation in racial\/ethnic minorities"],"prefix":"10.1182","volume":"8","author":[{"given":"Nandita","family":"Khera","sequence":"first","affiliation":[{"name":"1Department of Hematology\/Oncology, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikander","family":"Ailawadhi","sequence":"additional","affiliation":[{"name":"2Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[{"name":"3Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI"},{"name":"4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9301-9941","authenticated-orcid":false,"given":"Jinalben","family":"Patel","sequence":"additional","affiliation":[{"name":"4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Jacobs","sequence":"additional","affiliation":[{"name":"4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-6213","authenticated-orcid":false,"given":"Celalettin","family":"Ustun","sequence":"additional","affiliation":[{"name":"5Division of Hematology, Oncology, and Cell Therapy, Rush University, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ballen","sequence":"additional","affiliation":[{"name":"6Division of Hematology\/Oncology, University of Virginia Health System, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-0445","authenticated-orcid":false,"given":"Muhammad Bilal","family":"Abid","sequence":"additional","affiliation":[{"name":"7Divisions of Hematology\/Oncology & Infectious Diseases, BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5286-1329","authenticated-orcid":false,"given":"Miguel Angel","family":"Diaz Perez","sequence":"additional","affiliation":[{"name":"8Department of Hematology\/Oncology, Hospital Infantil Universitario Ni\u00f1o Jesus, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Samer","family":"Al-Homsi","sequence":"additional","affiliation":[{"name":"9New York University Grossman School of Medicine, Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-4726","authenticated-orcid":false,"given":"Hasan","family":"Hashem","sequence":"additional","affiliation":[{"name":"10Division of Pediatric Hematology\/Oncology and Bone marrow Transplantation, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghee","family":"Hong","sequence":"additional","affiliation":[{"name":"11Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Munker","sequence":"additional","affiliation":[{"name":"12Markey Cancer Center, University of Kentucky, Lexington, KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel M.","family":"Schears","sequence":"additional","affiliation":[{"name":"13University of Central Florida, Department of Emergency Medicine, Orlando, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[{"name":"14University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-3271","authenticated-orcid":false,"given":"Stefan","family":"Ciurea","sequence":"additional","affiliation":[{"name":"15Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, University of California, Irvine, Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-265X","authenticated-orcid":false,"given":"Sherif M.","family":"Badawy","sequence":"additional","affiliation":[{"name":"16Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL"},{"name":"17Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-9965","authenticated-orcid":false,"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[{"name":"18Division of Hematology\/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldeep","family":"Wirk","sequence":"additional","affiliation":[{"name":"19Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-0186","authenticated-orcid":false,"given":"C. Fred","family":"LeMaistre","sequence":"additional","affiliation":[{"name":"20Sarah Cannon, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2033-1125","authenticated-orcid":false,"given":"Neel S.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"21Division of Hematology\/Oncology and Bone Marrow Transplant, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA"},{"name":"22Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Beitinjaneh","sequence":"additional","affiliation":[{"name":"23Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[{"name":"24Oncology Center, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-2081","authenticated-orcid":false,"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[{"name":"25Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6602-5505","authenticated-orcid":false,"given":"Jan","family":"Cerny","sequence":"additional","affiliation":[{"name":"26Division of Hematology\/Oncology, Department of Medicine, University of Massachusetts Chan Medical School and Medical Center, Worcester, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-3109","authenticated-orcid":false,"given":"Jennifer M.","family":"Knight","sequence":"additional","affiliation":[{"name":"27Division of Hematology\/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI"},{"name":"28Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI"},{"name":"29Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7627-8509","authenticated-orcid":false,"given":"Amar H.","family":"Kelkar","sequence":"additional","affiliation":[{"name":"30Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean A.","family":"Yared","sequence":"additional","affiliation":[{"name":"31Transplantation & Cellular Therapy Program, Division of Hematology\/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamila","family":"Kindwall-Keller","sequence":"additional","affiliation":[{"name":"32MetroHealth System, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-1594","authenticated-orcid":false,"given":"Lena E.","family":"Winestone","sequence":"additional","affiliation":[{"name":"33Division of Allergy, Immunology, and Blood & Marrow Transplant, University of California, San Francisco Benioff Children\u2019s Hospitals, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Steinberg","sequence":"additional","affiliation":[{"name":"34Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-8521","authenticated-orcid":false,"given":"Staci D.","family":"Arnold","sequence":"additional","affiliation":[{"name":"35Aflac Cancer and Blood Disorder Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4308-2152","authenticated-orcid":false,"given":"Sachiko","family":"Seo","sequence":"additional","affiliation":[{"name":"36Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-5720","authenticated-orcid":false,"given":"Jaime M.","family":"Preussler","sequence":"additional","affiliation":[{"name":"37Center for International Blood and Marrow Transplant Research, National Marrow Donor Program\/Be The Match, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-655X","authenticated-orcid":false,"given":"Nasheed M.","family":"Hossain","sequence":"additional","affiliation":[{"name":"38Divisions of Hematology\/Oncology, Department of Medicine, Cell Therapy and Transplantation Program, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-1583","authenticated-orcid":false,"given":"Warren B.","family":"Fingrut","sequence":"additional","affiliation":[{"name":"39Harvard T.H. Chan School of Public Health, Boston, MA"},{"name":"40Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Agrawal","sequence":"additional","affiliation":[{"name":"41Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-7927","authenticated-orcid":false,"given":"Shahrukh","family":"Hashmi","sequence":"additional","affiliation":[{"name":"42Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE"},{"name":"43Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN"},{"name":"44College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie E.","family":"Lehmann","sequence":"additional","affiliation":[{"name":"45Dana Farber Boston Children\u2019s Cancer and Blood Disorder Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[{"name":"46Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-2920","authenticated-orcid":false,"given":"Hemalatha G.","family":"Rangarajan","sequence":"additional","affiliation":[{"name":"47Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children\u2019s Hospital, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[{"name":"4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Hahn","sequence":"additional","affiliation":[{"name":"48Department of Cancer Prevention & Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"2024070913003130900_bib1","unstructured":"Auletta\n              JJ KJ\n            , ChenM, ShawBE. Current Use and Outcome of Hematopoietic Stem Cell Transplantation: CIBMTR US Summary Slides. CIBMTR. Accessed 20 December 2022. https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.asp."},{"issue":"24","key":"2024070913003130900_bib2","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant\u2013related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"issue":"19","key":"2024070913003130900_bib3","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","article-title":"Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors","volume":"31","author":"Hahn","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2024070913003130900_bib4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.bbmt.2013.04.027","article-title":"Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age","volume":"19","author":"McCarthy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"2024070913003130900_bib5","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2024070913003130900_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"issue":"11","key":"2024070913003130900_bib7","doi-asserted-by":"crossref","first-page":"911.e1","DOI":"10.1016\/j.jtct.2021.08.014","article-title":"Outcomes and utilization trends of front-line autologous hematopoietic cell transplantation for mantle cell lymphoma","volume":"27","author":"Riedell","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"2024070913003130900_bib8","doi-asserted-by":"crossref","first-page":"346.e1","DOI":"10.1016\/j.jtct.2023.03.007","article-title":"Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"14","key":"2024070913003130900_bib9","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.2021012830","article-title":"Structural racism is a mediator of disparities in acute myeloid leukemia outcomes","volume":"139","author":"Abraham","year":"2022","journal-title":"Blood"},{"issue":"15","key":"2024070913003130900_bib10","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"issue":"7","key":"2024070913003130900_bib11","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1200\/JCO.1997.15.7.2644","article-title":"Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors","volume":"15","author":"Mitchell","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"2024070913003130900_bib12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbmt.2014.12.024","article-title":"Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma","volume":"21","author":"Costa","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"28","key":"2024070913003130900_bib13","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1200\/JCO.2005.01.7269","article-title":"Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States","volume":"23","author":"Baker","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"2024070913003130900_bib14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbmt.2011.10.040","article-title":"Relationship of race\/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes","volume":"18","author":"Ballen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2024070913003130900_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbmt.2004.12.327","article-title":"Effects of race on survival after stem cell transplantation","volume":"11","author":"Mielcarek","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2024070913003130900_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3324\/haematol.2012.063602","article-title":"Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups","volume":"98","author":"Pulte","year":"2013","journal-title":"Haematologica"},{"key":"2024070913003130900_bib17","unstructured":"US Census Bureau\n          . 2020 US population more racially and ethnically diverse than measured in 2010. Accessed 20 December 2022. https:\/\/www.census.gov\/library\/stories\/2021\/08\/2020-united-states-population-more-racially-ethnically-diverse-than-2010.html."},{"issue":"4","key":"2024070913003130900_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. Registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"2024070913003130900_bib19","volume-title":"U.S. Dept. of Health and Human Services OotS, Office of the Assistant Secretary for Planning and Evaluation and Office of Minority Health. HHS Action Plan to Reduce Racial and Ethnic Health Disparities Implementation Progress Report","year":"2015"},{"issue":"suppl 24","key":"2024070913003130900_bib20","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1002\/cncr.30899","article-title":"Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: findings from the CONCORD-2 study","volume":"123","author":"Tai","year":"2017","journal-title":"Cancer"},{"issue":"suppl 24","key":"2024070913003130900_bib21","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1002\/cncr.31076","article-title":"Colon cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study","volume":"123","author":"White","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"2024070913003130900_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2024070913003130900_bib23","unstructured":"Tong\n              M HL\n            , ArtigaS. Racial Disparities in Cancer Outcomes, Screening, and Treatment. KFF. Accessed 22 December 2022. https:\/\/www.kff.org\/racial-equity-and-health-policy\/issue-brief\/racial-disparities-in-cancer-outcomes-screening-and-treatment\/."},{"issue":"25","key":"2024070913003130900_bib24","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMp2200244","article-title":"The emergence of the racial disparity in U.S. breast-cancer mortality","volume":"386","author":"Jatoi","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"2024070913003130900_bib25","unstructured":"US Census Bureau\n          . Explore Census Data. Accessed 22 December 2022. https:\/\/data.census.gov\/."},{"issue":"12","key":"2024070913003130900_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.bbmt.2009.07.023","article-title":"Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation","volume":"15","author":"Baker","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2024070913003130900_bib27","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/cncr.29160","article-title":"Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study","volume":"121","author":"Bhatnagar","year":"2015","journal-title":"Cancer"},{"issue":"16","key":"2024070913003130900_bib28","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/cncr.30747","article-title":"Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report","volume":"123","author":"Schriber","year":"2017","journal-title":"Cancer"},{"issue":"8","key":"2024070913003130900_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am J Hematol"},{"issue":"3","key":"2024070913003130900_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbmt.2009.11.007","article-title":"Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma","volume":"16","author":"Hari","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"2024070913003130900_bib31","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1002\/cam4.4249","article-title":"Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States","volume":"10","author":"Vaughn","year":"2021","journal-title":"Cancer Med"},{"issue":"14","key":"2024070913003130900_bib32","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/cncr.25297","article-title":"Access to hematopoietic stem cell transplantation: effect of race and sex","volume":"116","author":"Joshua","year":"2010","journal-title":"Cancer"},{"issue":"20","key":"2024070913003130900_bib33","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","article-title":"Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis","volume":"3","author":"Ailawadhi","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"2024070913003130900_bib34","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.bbmt.2013.08.002","article-title":"Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma","volume":"19","author":"Costa","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024070913003130900_bib35","unstructured":"Madeline Guth\n              MA\n            \n          . Building on the Evidence Base: Studies on the Effects of Medicaid Expansion, February 2020 to March 2021. KFF. Accessed 26 December 2022. https:\/\/www.kff.org\/report-section\/building-on-the-evidence-base-studies-on-the-effects-of-medicaid-expansion-february-2020-to-march-2021-appendix-a\/."},{"issue":"8","key":"2024070913003130900_bib36","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/jnci\/djac077","article-title":"Association between Medicaid expansion under the Affordable Care Act and survival among newly diagnosed cancer patients","volume":"114","author":"Han","year":"2022","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"25","key":"2024070913003130900_bib37","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2024070913003130900_bib38","doi-asserted-by":"crossref","first-page":"e0174760","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"2024070913003130900_bib39","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.20628","article-title":"Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas","volume":"101","author":"Hwang","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"2024070913003130900_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/ehm.10.21","article-title":"Allogeneic hematopoietic cell transplantation: the state of the art","volume":"3","author":"Gyurkocza","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"2024070913003130900_bib41","unstructured":"SEER\n          . Cancer Stat Facts: Leukemia \u2014 Acute Lymphocytic Leukemia (ALL). Accessed 22 December 2022. https:\/\/seer.cancer.gov\/statfacts\/html\/alyl.html#:\u223c:text=Acute%20lymphocytic%20leukemia%20is%20most%20common%20in%20children%2C,women%20per%20year%20based%20on%202014%E2%80%932018%20cases%2C%20age-adjusted."},{"issue":"20","key":"2024070913003130900_bib42","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1200\/JCO.2003.03.133","article-title":"Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada","volume":"21","author":"Serna","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"spec no 2","key":"2024070913003130900_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/geronb\/60.Special_Issue_2.S68","article-title":"Aging, migration, and mortality: current status of research on the Hispanic paradox","volume":"60","author":"Markides","year":"2005","journal-title":"J\u00a0Gerontol B Psychol Sci Soc Sci"},{"key":"2024070913003130900_bib44","unstructured":"National Center for Health Statistics\n          . Mortality trends by race and ethnicity among adults aged 25 and over: United States, 2000\u20132017. Accessed 26 December 2022. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db342.htm."},{"issue":"4","key":"2024070913003130900_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006252","article-title":"Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis","volume":"137","author":"Bona","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2024070913003130900_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12910-017-0179-8","article-title":"Implicit bias in healthcare professionals: a systematic review","volume":"18","author":"FitzGerald","year":"2017","journal-title":"BMC Med Ethics"},{"key":"2024070913003130900_bib47","unstructured":"US Census Bureau\n          . 2020 U.S. Population More Racially, Ethnically Diverse Than in 2010. Accessed 24 December 2022. https:\/\/www.census.gov\/library\/stories\/2021\/08\/2020-united-states-population-more-racially-ethnically-diverse-than-2010.html."},{"issue":"8","key":"2024070913003130900_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28877","article-title":"Geographic and racial disparities in access to chimeric antigen receptor\u2013T cells and bispecific antibodies trials for multiple myeloma","volume":"5","author":"Alqazaqi","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2024070913003130900_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jtct.2022.04.008","article-title":"Socioeconomic and racial disparity in chimeric antigen receptor T cell therapy access","volume":"28","author":"Ahmed","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"2024070913003130900_bib50","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtct.2022.09.020","article-title":"The ASTCT-NMDP ACCESS initiative: a collaboration to address and sustain equal outcomes for all across the hematopoietic cell transplantation and cellular therapy ecosystem","volume":"28","author":"Auletta","year":"2022","journal-title":"Transplant Cell Ther"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/13\/3497\/2233823\/blooda_adv-2023-012469-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/13\/3497\/2233823\/blooda_adv-2023-012469-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:01:18Z","timestamp":1720530078000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/13\/3497\/515893\/Trends-in-volumes-and-survival-after-hematopoietic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":50,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012469","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}